DSIP Afira 5 mg / 3 ml ( Delta Sleep-Inducing Peptide)

DSIP stands for Delta Sleep-Inducing Peptide. It is a peptide that has been studied in relation to sleep regulation and neuroendocrine processes.

The most well-known area is sleep: the speed of falling asleep, the duration of sleep, the number of awakenings at night, and its structure. There are small studies in humans, but the results are not clear.

Early studies have shown potential for changes in some sleep parameters, but some controlled studies have failed to demonstrate a clinically meaningful effect. Therefore, DSIP cannot be considered a proven treatment for insomnia.

Some small studies have shown a reduction in sleep latency, or the time it takes to fall asleep, but the evidence is not strong enough to guarantee this effect.

The name Delta Sleep-Inducing Peptide may give that impression, but available research does not allow us to claim that DSIP is guaranteed to increase deep sleep in humans.

No. DSIP should not be equated with registered sleeping pills. It is a peptide that has been studied in experimental sleep studies.

Yes. There are small clinical studies in humans, particularly in patients with chronic insomnia. However, most of these studies are old and included small numbers of participants.

Some early studies assessed the number of nighttime awakenings and the time spent awake after falling asleep, but the results do not promise a consistent effect.

DSIP has been studied in relation to the HPA axis. One small study observed a decrease in ACTH-like immunoreactivity, but cortisol levels were unchanged.

The presented Afira format contains DSIP 5 mg/3 ml in a pre-filled pen.

DSIP Afira 5 mg / 3 ml is presented in the Nova Vroda catalog. On the product page you can view the current price, specifications and product information.